CV risk in patients with type 2 diabetes
Educational program and resources for nurses that increases awareness of cardiovascular risk in patients with type 2 diabetes and established cardiovascular disease (CVD) to optimize management and reduce risk.
CV risk in patients with type 2 diabetes
Educational program and resources for nurses that increases awareness of cardiovascular risk in patients with type 2 diabetes and established cardiovascular disease (CVD) to optimize management and reduce risk.
This educational series consists of customized tracks for nurses, cardiac nurses, and nurse practitioners, and aims to provide information to aid in optimizing the management of patients with type 2 diabetes and cardiovascular risk factors or established CVD. This program looks at the scope of the problem, the link between type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD), and current ways to manage these patients. The most recent medical society guidelines are included which provide an overview of the recommended treatment options for managing patients with type 2 diabetes and ASCVD.
In order to provide you with the most relevant educational content corresponding to your area of expertise, please select the appropriate track below to begin the program.*
In order to provide you with the most relevant educational content corresponding to your area of expertise, please select the appropriate track below to begin the program.*
Please Select a Track:
Requires a novoMEDLINK™ account
Nurse
Cardiac Nurse
Nurse Practitioner
*This program has been developed by Novo Nordisk in collaboration with the Preventive Cardiovascular Nurses Association (PCNA) to bring you up to date content designed specifically for the nursing community. PCNA received financial support from Novo Nordisk for review of the program and related co-promotional and advertising opportunities.
This is a promotional education program; it will not be certified for continuing medical education credit.